// App-Quantinova.ai

570 : Long-term efficacy and downstream mechanism of anti-Annexin A2 monoclonal antibody in a pre-clinical model of aggressive human breast cancer

Researchers

Presenter

  • Mahesh C. Sharma

Principal Investigators

  • George P. Tuszynski

  • Marc R. Blackman

  • Meena Sharma

Medical Centers

  • VA Medical Center Washington DC, Washington, DC

  • Temple University School of Medicine, Philadelphia, PA

  • University of Pennsylvania, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

  • Triple-negative breast cancer

Biomarkers

  • Matrix metallopeptidase 9

  • Matrix metalloproteinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved